Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which IV fluid works best for kids with stomach bugs? new study aims to find out

NCT ID NCT07610382

Knowledge-focused Sponsor: Aydin Adnan Menderes University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at two common IV fluids given to children aged 6 months to 5 years who are dehydrated from a stomach bug. The goal is to see if one type helps restore normal blood chemistry faster than the other. Doctors choose the fluid as part of normal care, and the research team simply observes the results without any extra tests or procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Consecutive eligible children aged 6 months to 5 years presenting to the paediatric emergency department of Aydin Adnan Menderes University Hospital with acute gastroenteritis and a clinician-initiated indication for intravenous rehydration. Enrolment is prospective and observational; the treating physician independently determines IV fluid type and dose based on clinical judgment, without involvement from the research team.

Ages

6 months to 5 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age: 6 months to 5 years (60 months) inclusive * Clinical diagnosis of acute gastroenteritis: acute diarrhoea (3 or more loose stools per 24 hours) with or without vomiting; symptom duration 7 days or less * Clinician-initiated indication for intravenous rehydration * IV fluid order placed and treatment initiated independently by the treating physician, without research team influence Exclusion Criteria: * Chronic systemic disease (congenital heart disease, chronic kidney disease, chronic lung disease, inborn errors of metabolism, primary immunodeficiency) * Hypernatraemic dehydration (serum sodium \>= 150 mEq/L at baseline) * Diabetic ketoacidosis, primary metabolic crisis, or suspected surgical abdomen * Bloody diarrhoea or suspected invasive enteric infection requiring alternative management algorithm * Hypoglycaemia (blood glucose \< 60 mg/dL) at presentation * Symptom duration exceeding 7 days * Receipt of 20 mL/kg or more of IV fluid in the 24 hours preceding enrolment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acidosis, metabolic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Acidosis Dehydration diarrheal disease gastroenteritis metabolic acidosis Vomiting

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acidosis, metabolic Dehydration Diarrhea Gastroenteritis acute Vomiting

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Aydin Adnan Menderes University Hospital, Department of Pediatric Emergency Care

    RECRUITING

    Aydin, 09100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.